← Back to searchRecruitingRecruiting
Telehealth Collaborative Care Model (CoCM) in Lung Cancer
NCT07102147 · Abramson Cancer Center at Penn Medicine
In plain English
Click the button to translate this study into plain language — what it is, who qualifies, and what participation looks like.
Official title
Increasing Adoption of a Telehealth-Delivered Collaborative Care Program for Patients With Lung Cancer: A Pilot Study
About this study
The goal of this project is to pilot test the effectiveness of using a more-intensive (high touch) outreach strategy to increase the reach of an adapted, standard of care CoCM for patients with lung cancer who are experiencing depression and/or anxiety. The investigators will specifically test the effect of two outreach strategies (high touch vs. standard outreach) on reach of the CoCM program (primary outcome) and on several secondary implementation and effectiveness outcomes. Given the demonstrated efficacy of the CoCM in patients with cancer, the main target of this research study is the impact of the outreach strategies and delivery of the CoCM via telehealth.
Eligibility criteria
Inclusion Criteria:
* Are aged 18 years or older.
* Are currently being seen by Penn Medicine Thoracic Oncology for lung cancer treatment or survivorship care.
* Are referred to collaborative care by a Penn Medicine Thoracic Oncology clinician for treatment of depression, anxiety, or other psycho-therapy services.
Exclusion Criteria:
* Are already receiving psycho-therapy treatment services outside of Penn Medicine's collaborative care program, Penn Integrated Care (PIC).
* Have a significant and/or untreated medical and/or psychiatric co-morbidity (e.g., other cancers, schizophrenia, acute suicidal and/or homicidal ideation) that make them ineligible for the Penn CoCM program.
Study design
Enrollment target: 30 participants
Allocation: randomized
Masking: double
Age groups: adult, older_adult
Timeline
Starts: 2025-08-18
Estimated completion: 2027-02
Last updated: 2025-10-15
Interventions
Behavioral: High Touch Outreach
Primary outcomes
- • Reach - Completion of the intake assessment amongst referred patients. (Measured per patient up to 30 days after randomization.)
Sponsor
Abramson Cancer Center at Penn Medicine · other
With: National Institutes of Health (NIH), National Cancer Institute (NCI)
Contacts & investigators
ContactJennifer Steltz, MRA · contact · jennifer.steltz@pennmedicine.upenn.edu · 215-573-2593
ContactJocelyn Wainwright, MS · contact · jocelyn.wainwright@pennmedicine.upenn.edu · 215-615-4226
InvestigatorAlexandria Muench, PsyD · principal_investigator, University of Pennsylvania
All locations (1)
Abramson Cancer Center at the University of PennsylvaniaRecruiting
Philadelphia, Pennsylvania, United States